pets: the cashflow

MyFinsight

For the year ending 2025-03-31.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-03-31
Net sales	226,972
Cost of sales	157,835
Advertising	23,781
Other segment expenses	44,684
Adjusted ebitda	672
Share-based compensation (reversal) expense	-6,586
Income taxes	5,684
Depreciation and amortization	7,039
Interest income	185
Acquisition/partnership transactions and other items	231
Employee severance	738
Sales tax expense (reversal)	-1,178
Impairment loss	1,200
Net (loss) income	-6,271
Depreciation and amortization	7,039
Impairment loss	1,200
Share based compensation, net	-6,586
Deferred income taxes	5,249
Bad debt expense	365
Accounts receivable	-601
Inventories	-12,351
Prepaid income taxes	111
Prepaid expenses and other current assets	-995
Operating lease right-of-use assets, net	-466
Accounts payable	-13,460
Sales tax payable	-145
Accrued expenses and other current liabilities	3,921
Operating lease liabilities	-458
Deferred revenue	-518
Income taxes payable	80
Net cash provided by operating activities	4,718
Purchase of minority interest investment in vetster	0
Acquisition of petcarerx, net of cash acquired	0
Purchases of property and equipment	5,113
Net cash used in investing activities	-5,113
Dividends paid	181
Net cash used in financing activities	-181
Net decrease in cash and cash equivalents	-576
Cash and cash equivalents at beginning of period	55,296
Cash and cash equivalents at end of period	54,720

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

pets: the cashflow